Tech Company Financing Transactions

Ambys Medicines Funding Round

Ambys Medicines closed a $47 million Series A financing round on 12/22/2021. Backers included Third Rock Ventures, Alexandria Venture Investments and Laurion Capital Management.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

131 Oyster Point Blvd. 200
San Francisco, CA 94080
USA

Phone

(650) 481-7660

Website

www.ambys.com

Email Address

[email protected]

Overview

Ambys Medicines is working to fundamentally transform the lives of people suffering from severe liver diseases by creating breakthrough therapies capable of restoring liver function, preventing the progression of liver disease, and treating the devastating complications of liver failure.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Jonker

        

Chief Medical Officer

Glenn Pierce

        

Chief Scientific Officer

Michael Holmes

        

Controller

Ran Xiao

        

Vice President

Stanley Hollenbach

        

VP - Bus. Development

Deidre Roniger

        

VP - Human Resources

Amanda Valentino

        

Browse more venture capital transactions:

Prev: 12/22/2021: PlainID venture capital transaction
Next: 12/22/2021: Planet42 venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We record funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary